Among patients with severe community-acquired pneumonia and high initial inflammatory response, the use of the corticosteroid methylprednisolone decreased treatment failure, compared with placebo, according to a study in the February 17 issue of JAMA.
from The Medical News http://ift.tt/1G0B0we
from The Medical News http://ift.tt/1G0B0we
No comments:
Post a Comment